BDD
Generated by Meeveem AI
"Accelerating early drug development from formulation to Phase I clinical data"
Glasgow
•51 - 250 Employees
•Contract Research
About BDD
BDD delivers integrated pharmaceutical development services spanning formulation, GMP manufacturing, and Phase I clinical trials. Its proprietary Lean Clinical Development approach eliminates unnecessary steps in early drug development, enabling faster time to clinical data through seamless coordination across all three capabilities under one roof. Established in 1999, BDD combines over 25 years of drug delivery expertise with industry leading clinical recruitment rates and on site MHRA accredited manufacturing. The company specializes in complex and controlled release formulations, including its OralogiK technology for precise timed delivery, supporting pharmaceutical companies, biotech firms, and research institutions worldwide.
54
Team Members
1999
Founded
Contract Research
Sector
On-Site
Work Environment
Our Vision
A pharmaceutical development landscape where early phase drug testing is faster, smarter, and more cost effective, accelerating the path from laboratory to patient without compromising scientific rigor or safety.
Our Mission
BDD exists to speed up the development of new medicines for the improvement of patient lives by combining rapid early clinical testing with an unrivalled knowledge of how dosage forms work in the body.